Karol E., Assoc. Director, Statistical Genetics & Genetic Epidemiology

May 07, 2018

Karol discusses how Biogen is using human genetics to identify targets for new drugs. Karol’s work in Alzheimer’s disease is an example of how Biogen is working to develop therapies to potenitally address unmet need. 

 

Explore careers at Biogen